About this journal
The Journal of Movement Disorders (JMD; pISSN 2005-940x; eISSN 2093-4939) is a peer-reviewed open access journal that officially represents the Korean Movement Disorder Society (KMDS). The ISO abbreviation of the title is “J Mov Disord”. JMD launched on April 30, 2008, with Issue 1 of Volume 1. JMD has been published triannually since 2015 and is released on the last days of January, May, and September. There is no articleprocessing charge or page charge issued to authors. All of the journal’s content (including supplementary data) is freely available at http://www.e-jmd.org. The JMD is currently indexed, tracked, and covered by PubMed, PubMed Central (PMC), ESCI by Thomson Reuters, Korea Citation Index (KCI), DOAJ, KoreMed, CrossRef, and Google Scholar. Subscription to JMD is free for members of KMDS and contributors to JMD or KMDS. For subscription or inquiries, please contact the JMD editorial office (Ms. Soo Jung Shin, firstname.lastname@example.org).
Aims and Scope
The JMD is dedicated to publishing translational and clinical studies for advancement in the field of movement disorders and neurodegenerative disorders with an emphasis on knowledge that will influence clinical neurology and neuroscience. Disorders of interest include but are not limited to movement disorders, Parkinson’s disease and other Parkinsonian disorders, neurodegenerative disorders, and neurogenetic disorders related to dysfunction of motor control or neurodegeneration. JMD has a broad international perspective. JMD encourages submissions that address epidemiology, genetics/genomics, diagnosis, management, and the prognosis of movement disorders from countries around the world. We have a particular interest in studies on Parkinson's disease or other movement disorders in Asian-Oceanian populations. These articles will broaden our understanding of the above topics against diverse ethnic and cultural backgrounds. All article formats are welcome, e.g., original articles of therapeutic trials and other experimental and observational studies, experimental and observational case reports, and review articles. JMD also welcomes articles that address bioinformatics or neuroimage analysis tools as long as they are related with the above disorders.
Types of Manuscript
The JMD publishes Review Articles, Original Articles, Brief communications, Letters to the Editor, and articles commissioned by the Editorial Committee. All manuscripts are subject to peer review.
- Review Articles: For Reviews, the authors should contact the Editorial Committee before submitting a manuscript. Review includes an abstract with no more than 250 words. The abstract for review does not need to be structured. There is no length limitation for a review article; however, we encourage authors to conform to the following limitations. The word count for the main text should be less than 5,000 words. The total number of figures and tables for review should be no more than 7. The number of references should be less than 200.
- Original Articles: Original articles should include structured abstract (no more than 250 words), main text (less than 4,000 words), and no more than 40 references. Total number of figures and tables should be no more than 7. Supplementary materials can be published online.
- Brief Communications: Brief communications should include a short original research, a preliminary study, or a case series. Brief communications should be structured abstract (no more than 150 words), main text (less than 1500 words), no more than 2 illustrations (figure/ table), and no more than 20 references. Supplementary materials can be published online.
- Letters to the Editor:
Case report describing one or two cases with novel or education clinical features could be submitted as Letter to the Editor. Letters to the Editor should be a brief description of a case or cases with short discussions with fewer than 1,000 words of main text, one table or figure, and no more than 7 references. An abstract is not required. Supplementary materials, including videos, can be published online.
The journal of Movement Disorders adheres to the ethical guidelines for research and publication described by the Committee on Publication Ethics (COPE, http://publicationethics.org) and the ICMJE Guidelines (http:// www.icmje.org). A submitted manuscript must not be associated with any type of research misconduct, including fabrication, falsification, and plagiarism with intent the authors’ to deceive. The cover letter to the Editor-in-Chief must declare that a submitted manuscript has not been published and is not under simultaneous consideration for publication elsewhere in whole or in part in any language except in the form of an abstract. The cover letter must also state whether the manuscript contains any portion that may be considered redundant or duplicate information, defined as a paper, data, tables, or figures that overlap substantially with previously published information.
Authorship and author’s responsibility
Authorship should be limited to those who contributed significantly (or a specific role) such as the conception, design, execution, or interpretation of the submitted study. Taking primary responsibility for communication, the corresponding author should be available not only during the entire submission and review process, but also after publication to respond to any critiques or requests from the journal for data. All authors are responsible for all works of the research paper.
Any changes of authorship such as addition, deletion or rearrangement of author names should be made only before acceptance of the manuscript and only if approved by the Editorial Board. To change authorship, the corresponding author should provide i) the reason for the authorship change and ii) written confirmation (through e-mail or cover letter) from all authors that they all agree with the authorship change of addition, removal or rearrangement.
Originality and duplicate publications
Manuscripts under the process of submission/review/revision or accepted/published by other journals will not be accepted for publication. In addition, the submission of duplicate publications with similar data will not be accepted for publication without permission of the Editorial Board.
All authors should confirm that all data were the authors’ own. If any work including words of others is utilized in their manuscript, authors should cite or quote this appropriately. In addition, to avoid “self-plagiarism”, any part work of the manuscript has not been published previously, unless authors disclose a specific aim or expansion of the previous work. Transparency on the re-use should be clearly provided.
Declaration of interest
All authors should disclose any potential or financial conflict of interest to influence their work.
Human and animal rights
The author should indicate within the manuscript that the submitted study was approved by the relevant research ethics committee or Institutional Review Board (IRB). Research involving human subjects must comply with the principles of the Declaration of Helsinki (1964). Articles that describe research involving animals must state in the Methods section that the work was approved by the applicable institutional ethics committee or review board. The manuscript must also state that informed consent was obtained from the subjects, when appropriate.
When the journal faces suspected cases of research and publication misconduct–such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer’s appropriation of an author’s idea or data, and complaints against editors–the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). Discussion and decisions on the suspected cases are carried out by the Editorial Board.
The copyright of published manuscripts is held by the Korean Movement Disorder Society. The authors must remember that the use of data, tables, figures, or videos (except for lectures) published in the JMD without written permission of the copyright holder is plagiarism, even if the authors use them from their own papers.
Online Submission Information
The JMD offers authors Web-based manuscript submission and peer review at http://www.e-jmd.org. Please review the instructions at the website carefully and take note of the further instructions provided at the top of each screen of the five-stage submission process. Submit your manuscript and all figures exactly as instructed to avoid failure or delay in processing.
Users must register when accessing the JMD online submission system for the first time, by clicking on “Register”. You will be asked to complete three steps in order to obtain your personal account.
We strongly recommend using your email address as your ID, since this represents a unique and easy-to-remember identifier that will be needed each time you log onto the system (as a reviewer or author). The password will be encrypted for security reasons, and will not be known to JMD. A verification email will be sent to you at the address you used to register.
Once you have verified your email address, you will be asked to provide a basic profile consisting of your contact information.
The JMD asks ORCID iD to first and corresponding authors in the process of online submission.
Uploading a Manuscript
At the JMD online submission system, click on the “Submit a new manuscript” link. You will be presented with a series of fields for entering information about your manuscript and uploading the manuscript, image, and supplemental files.
The system will automatically convert your files into a single PDF file for the review procedure. You will be asked to approve the conversion before your manuscript is formally submitted to the JMD. The conversion process can take up to 30 minutes, and an email will be sent informing you when the conversion is complete. Click on “Ready for you to proof” in the author area to check that the manuscript has been converted correctly.
You may begin a submission or continue the process at a later date by clicking on “Save/Continue” at the bottom of the screen when entering your manuscript information. This enables you to save that page or continue to the next page. If you choose not to complete the submission during a particular session, your manuscript will appear in the “incomplete submission” queue under “My Manuscript”. Do not submit the same paper more than once.
After completing the submission, the manuscript number will be sent to the email address specified, and this must be quoted in all subsequent communications. This email notification will be sent after we have confirmed that the submitted manuscript is consistent with the journal style. Manuscripts that do not conform to the style of the JMD might be returned without further review, requiring you to correct the style of the manuscript before resubmitting it.
For a blind review, do not include author information on the title page. Instead, provide the author information page as a separate file when uploading the manuscript. Prepare the title page as the first page of the main document file. The abstract should appear on page 2 of the main document file.
Supplemental Data is content that the authors wish to make available online if the paper is accepted for publication. This is currently confined to video files.
Authors who submit online using the JMD online submission system can keep track of the progress of their manuscript through the peer-review process by visiting the JMD online submission page and clicking on “My Manuscript”.
Submitting a Revision
To submit a revised manuscript via the JMD online submission system, click on “Manuscript in Revision”. You will be presented with information on the original version of your manuscript, which should be edited as necessary. You will then be required to upload the files related to the revised version. Do not submit revisions with the edits displayed (e.g., the Track Changes tool in Microsoft Word should be turned off when making edits). Please include your responses to the reviewer comments and a cover letter to the Editor-in-Chief.
Peer Review Process
All contributions submitted to JMD are peer reviewed. The editorial office first reviews a manuscript for its format and adherence to the aims and scope of JMD. If the manuscript meets these two criteria, it is dispatched to three reviewers. All manuscripts are run through the CrossCheck to detect plagiarism. If a manuscript is suspected of plagiarism, the editors will contact the authors for explanation. In the peer-review process, authors’ names and affiliations are blinded, and the results of the CrossCheck are sent to reviewers. The reviewing process generally takes 3 weeks. Revisions may be required before the paper is finally accepted. Revision addressing reviewers’ comments and critiques does not necessarily guarantee the acceptance of the manuscript. The acceptance of a manuscript is based on the quality and originality of the research and its significance in the field of clinical neurology and neuroscience. Failure to resubmit the revised manuscript within the indicated time is regarded as a withdrawal. A final decision on acceptance/rejection for publication is forwarded to the corresponding author by the editor.
THE ORDER AND FORMAT OF THE MANUSCRIPT
The manuscript should be arranged in the following orders: Cover letter, Author information page, Manuscript file (no author details), Tables, and Figures. Supplementary files should be presented in separate files. Supplementary tables can be prepared in Excel format. The text should be prepared in Microsoft Word Format (any version from Word 97 to Word 2013) and should be typed in font size 12, double-space between lines, and preferably in Times New Roman or Arial. Abbreviations should be used only for terms that are used at least twice and should be defined separately on first use in the Abstract and main text. Abbreviations for scientific units should conform to the Système Internationale (SI units). Place the page number in the middle of the bottom of each page from the title page onwards.
Drug Names: Use generic names only in referring to drugs, followed in parentheses after first mention by any commonly used generic variant.
The cover letter must contain the questions that authors found out to answer, the main findings of the study, and the significance of the study. It should also include why the readers of the journal would be interested in the study.
The following sentences should be contained in the cover letter.
All authors certify that this paper or any of its contents has not been published or submitted for publication elsewhere. All authors have full access to the data and the right to publish all the data. Each of the authors contributed to the work, and have seen and agreed with the contents of the manuscript. No ghost writing by anyone not named on the author list has occurred. All authors have agreed to submit the manuscript to the Journal of Movement Disorders.
AUTHOR INFORMATION PAGE
Titles should be short, specific, and informative. The first page should contain all the following information: title, the full names of all authors with their highest degrees (e.g., MD, PhD) and affiliations where the work was performed, a running title (less than 50 characters including spaces), and the contact information for the corresponding author including the complete address, telephone number, fax number, and email address. When there are multiple authors from multiple affiliations, use numbers as superscripts in the order of appearance (e.g., 1-3).
Sample title and author information
Relationship Between the Striatal and Cerebellar Glucose Metabolism and the Response to Levodopa Treatment in Patients with Multiple System Atrophy
Chul-Hyoung Lyoo,1 Seung Hun Oh,1 Ki Ook Lee,2 Seing Yeob Lee,1 Young Hoon Ryu,3 Myung-Sik Lee1
1Departments of Neurology and 2Radiology, Yonsei University College of Medicine, Seoul, Korea
3Department of Neurology, Konyang University Hospital, Daejeon, Korea
In addition, acknowledgement and compliance with ethical guidelines including conflicts of interest, author’s role, study funding, and the statement of ethical standard should be stated on a separate page under appropriate subheadings.
Those who contributed to the work but do not meet our authorship criteria should be listed in the Acknowledgments with a description of the contribution.
COMPLIANCE WITH ETHITICAL GUIDELINES
Conflicts of interest
All submissions require financial disclosure of all authors. A statement that documents all funding sources and potential conflicts of interest from each author that relate to the research covered in the article submitted must be included on this page, regardless of date. This material will be printed with the published article.
List all authors along with their specific roles in the project and preparation of the manuscript.
Authors should disclose the funding source of their work, if the study was supported by any institution or company.
For example) This work was supported by **** University Hospital Fund (Grant#: *******).
This statement should be required in any type of manuscript. If their work did not follow the ethical guidelines, the process for publication of the manuscript will not be considered.
For example) All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all the patients included in the study.
The title page should be the first page of the manuscript and should contain manuscript title, running title, number of characters of the title, number of words in the abstract, number of words in the manuscript (excluding references, and figure legends), number of tables, and number of figures. The author names should not appear on this page for the peer review process.
The Abstract must appear on a separate page. Abstracts for Original Articles and Brief Communications should be structured and organized into Objective, Methods, Results, and Conclusions, with these titles terminated with a colon and in boldface. All Original Articles must include structured abstracts that do not exceed 250 words, and be organized into Objective, Methods, Results, and Conclusions, with these titles terminated with a colon and in boldface. Abstracts are required for Reviews, but a structured format as in Original Articles is not necessary. Brief communications should be structured abstracts that do not exceed 150 words. Abstracts are not required for Letters to the editor. Between three and six keywords should be provided at the end of this page. Important terms can be selected from the Medical Subject Heading (MeSH) of Index Medicus.
The main body of the manuscript should be presented in the following sequence: Introduction, Materials & Methods, Results, and Discussion. In the Material & Methods within the manuscript, for Original article and Brief communication, Institutional Review Board (IRB) study number should be stated. Meanwhile, for Review and Letter to the editor, IRB study number should be described only when appropriate. The specific name of institution or hospital should not appear for the peer review process.
For example) This prospective study was approved by the local Institutional Ethics Committee (IRB #: ***********).
As a new policy of JMD, ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. Authors are encouraged to report sex distribution of study participants or samples in the Result section for all studies of humans, tissues, cells or animals. Where possible, we encourage authors to report data according to sex and discuss the influence of sex on study results. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
References should be numbered serially in the text using numbers as unparenthesized superscripts: 3,7,10-12. They should be listed on a separate sheet at the end of the paper in that order. Unpublished data and personal communications may be cited in the text (including the initials and surnames of all authors, and the year in which the observation was made), but should not be listed as references. Authors are responsible for the accuracy of references. Reference format should conform with that specified in “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”. Journal abbreviations should conform to the style used in the Cumulated Index Medicus. Do not reference papers that are “submitted”; these can be specified as unpublished data in the body of the text. Personal communications should also be mentioned in the body of the text only. List all authors when they are six or fewer; when there are seven or more, list only the first six and add “et al.”. The endnote reference style for Journal of Movement Disorders is specified on the journal homepage.
Journal article: Kim JE, Shin HW, Sohn YH. Chorea as an initial manifestation of polycythemia vera. J Mov Disord 2008;1:82-85.
Book: Wyllie E. The Treatment of Epilepsy. 2nd ed. Baltimore: Williams & Wilkins, 1997;97-98.
Book chapter: Calne CB, Duvoision RFC, McGeer E. Speculation on the etiology of Parkinson's disease. In: Hassler RG, Christ JF. Advances in Neurology. 2nd ed. Vol 40. New York: Raven. 1984;353-360.
Type each table, with a title, on a separate sheet. Each table should be included as a Word table in order to ensure correct column alignment. Cite and number tables in the order they are mentioned in the text. All abbreviations should be spelled out when they first appear in tables. For footnotes, use the following symbols in the indicated sequence: *, †, ‡, §, ∥, ¶, **, ††, and ‡‡. The significance of observations, as determined by appropriate statistical analyses, should be indicated.
Cite figures in numerical order (Figures 1 and 2, etc) as they appear in the text. Figures must be submitted as separate files saved in JPEG, TIFF, GIF, EPS, or PPT format (do not embedded the figures in the Microsoft Word manuscript file). The figure resolution should be at least 600 dpi for grayscale and color images, and 1,200 dpi for line figures at final size. Color images must be saved in CMYK mode (and not in RGB mode). Photographs of recognizable persons should be accompanied by a signed release from the patient or legal guardian authorizing publication. Legends for figures must appear on a separate page at the end of the manuscript file. The complete cost of reproducing color images will be charged to the authors. All color figures will be reproduced in full color in the online edition of the journal at no cost to authors.
SUBMISSION OF VIDEO
Video can be submitted with manuscript. If an article includes video, the author must mark the description “this article includes video” on the title page of the manuscript. Video must be brief: less than three minutes total, and its file size is no larger than 20 MB, except for very special instances. Videos should be named in the order of their text citation (e.g., video 1), and legends for the video segments should be incorporated into the article. Preferred video formats included “.wma, .mpg, or .mov” files. Avoid lengthy file names. Frame size should be limited to 450×375 pixels for best viewing within a browser on most monitors. If necessary, split the video into several clips.
Corresponding author is responsible for obtaining patient consent-to-disclose forms for any figures of identifiable patients and should edit out any names mentioned in the recording. The consent form should indicate specific use (reproduction in the medical literature in print and online, with the understanding that patients and the public will have access) of the patient’s medical information and any images and must contain the patient’s signature or that of a legal guardian. The original form must be retained by the corresponding author. Corresponding author must declare in the cover letter to the Editor-in-chief that the patient or his/her legal guardian signed the consent form for publication both in print and online. A copy of the patient Consent form must be uploaded through online submission system or faxed the Journal office.
Accepted Articles: Materials Required for Publication
The corresponding author should confirm electronic copyright transfer and author consent form in advance to the Editorial Office through online submission system, since manuscripts cannot be published unless these items are confirmed by the Editorial Office. You can find electronic copyright transfer and author consent form from the JMD online submission system. Please, remind that the patient Consent form must be faxed to the Editorial office via fax (+82-31-381-8820) or by an email (email@example.com).
Proofs and Reprints
The author(s) will receive the final version of the manuscript as a PDF file. Upon receipt, proofs must be returned within 3 days of re-ceipt; late return might delay the publication of a paper. Please check the text, tables, legends, and references very carefully. Substantial alterations by the authors other than the correction of printing errors might incur additional charges. Reprints of the article can be ordered by authors at the prices indicated on the reprint order form after the article is published. Please contact publishers to order reprints.
Page Charge or Article Processing Charge
There is no article-processing charge or page charge issued to authors.
Contact Information on Inquiry
Sun Ju Chung, M.D., Ph.D.
Asan Medical Center, University of Ulsan College of Medicine
Email: firstname.lastname@example.org, email@example.com
Editorial office (for editorial or business inquiry)
Soo Jung Shin
Managing editor, Journal of Movement Disorders
Hanhwa Obelisk Apt #2011, 33 Mapo-daero, Mapo-gu,
Seoul 04167, Republic of KOREA
Tel: +82-2-6395-2876 Fax: +82-2-6395-2875 Email: firstname.lastname@example.org